Skip to main content

Advertisement

Table 4 Number of adverse events (AE) in relation to dose administered (n = 155)

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Dose (mg) 200 400 700 1200 2000a 2000b 2000c
Clinical AE (n) 2 0 6 3 16 7 1
Laboratory AE (n) 16 16 16 20 14 12 25
  1. a n = 3 before DLT; b n = 3 after DLT; c n = 3 for 9 weeks